Showing 2161-2170 of 7669 results for "".
- Wound Repair Breakthrough: Protein Coacervates Engineered Into Adhesive for “Unprecedented” Skin Repair Speedhttps://practicaldermatology.com/news/wound-repair-breakthrough-protein-coacervates-engineered-into-adhesive-for-unprecedented-skin-repair-speed/2462032/A team of researchers from China is developing a novel biocomposite adhesive that may revolutionize wound management and tissue repair, according to a study in Engineering. Adhesives have long been recognized as a valuable tool in biomedical engineering. However, current adhesive systems face chal…
- Nevisense Detects Skin Barrier Damage In Skin Sampleshttps://practicaldermatology.com/news/nevisense-detects-skin-barrier-damage-in-skin-samples/2462031/Nevisense can measure skin barrier function in human excised skin samples, SciBase reports. For the study, Nevisense and its underlying Electrical Impedance Spectroscopy (EIS) technology were used to assess the effect of commercially available detergents on the skin barrier of mice and human skin …
- DEF, SDPA Call Attention to Heart Health for World Heart Dayhttps://practicaldermatology.com/news/def-sdpa-call-attention-to-heart-health-for-world-heart-day/2462027/The Dermatology Education Foundation (DEF) and the Society of Dermatology Physician Assistants (SDPA) are calling on NPs and PAs in dermatology to take charge of their own health and support peers in recognition of World Heart Day on September 29, 2023. “As nurse practitioners and physician assist…
- Abeona Submits BLA for RDEB Treatmenthttps://practicaldermatology.com/news/abeona-submits-bla-for-rdeb-treatment/2462026/Abeona Therapeutics Inc. submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of EB-101, its investigational autologous, engineered cell therapy, as a treatment for patients with recessive dystrophic epidermolysis bullosa (RDEB). As part …
- Study: Test Kids With AD for Allergic Contact Dermatitishttps://practicaldermatology.com/news/study-test-kids-with-ad-for-allergic-contact-dermatitis/2462025/Children with atopic dermatitis may also need to be tested for allergic contact dermatitis, according to a new study in the Journal of the American Academy of Dermatology. Researchers conducted a retrospective case-control study using the Pediatric Allergic Contact Dermatitis Registry from 2018 t…
- Cosmo, Glenmark Sign Distribution and License Agreements for Winlevi in Europe and South Africahttps://practicaldermatology.com/news/cosmo-glenmark-sign-distribution-and-license-agreements-for-winlevi-in-europe-and-south-africa/2462024/Glenmark Pharmaceuticals Ltd., now has exclusive rights to commercialize Winlevi (clascoterone cream 1%) in 15 EU countries (Bulgaria, the Czech Republic, Denmark, Finland, France, Hungary, Iceland, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain and Sweden) as well as in South …
- Revealed: Why Skin Feels “Tight” After Using a Facial Cleanserhttps://practicaldermatology.com/news/revealed-why-skin-feels-tight-after-using-a-facial-cleanser/2462023/Some cleansers make the skin feel “tight” and some moisturizers make the skin feel “soft,” but exactly why this occurs hasn't been fully understood. To find out, Reinhold H. Dauskardt, the Ruth G. and William K. Bowes Professor in Stanford’s Department of Materials Science and Engineering, and co…
- ASDS: Dermatologists Remain the Primary Influencer for Patients’ Cosmetic Procedures, Skin Care Decisionshttps://practicaldermatology.com/news/asds-dermatologists-remain-the-primary-influencer-for-patients-cosmetic-procedures-skin-care-decisions/2462022/Board certified dermatologists hold the most sway when it comes to choosing a provider, cosmetic procedure, or skin care product, according to the 2023 American Society for Dermatologic Surgery (ASDS) Consumer Survey on Cosmetic Dermatologic Procedures. Consumers reported that the top factors infl…
- Arcutis Launches Educational Campaign for People Living with Seborrheic Dermatitishttps://practicaldermatology.com/news/arcutis-launches-educational-campaign-for-people-living-with-seborrheic-dermatitis/2462021/Arcutis Biotherapeutics, Inc. is launching Clearing Up Seb Derm, a seborrheic dermatitis educational campaign. Clearing Up Seb Derm sheds light on the lack of information and understanding of seborrheic dermatitis, and how this condition has an impact beyond the skin, affecting people’s everyday …
- Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262https://practicaldermatology.com/news/escient-pharmaceuticals-initiates-clinical-proof-of-concept-study-of-ep262/2462020/The first patient has been dosed in Escient Pharmaceuticals CALM-CIndU, an open label Phase 1b clinical proof-of-concept study of EP262, a first-in-class oral MRGPRX2 antagonist for chronic inducible urticaria. By blocking activation of MRGPRX2 and degranulation of mast cells, EP262 has the potent…